pindolol has been researched along with Bright Disease in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The daily dosage of mepindolol was 5 mg for patients with glomerular filtration rates 30% and higher and 2." | 1.27 | The 24-hour control of blood pressure in hypertension of chronic renal disease with mepindolol. ( García Rohles, R; Parada, J; Rodríguez Alvariño, J; Ruilope, L, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parada, J | 1 |
| Ruilope, L | 1 |
| García Rohles, R | 1 |
| Rodríguez Alvariño, J | 1 |
1 other study available for pindolol and Bright Disease
| Article | Year |
|---|---|
The 24-hour control of blood pressure in hypertension of chronic renal disease with mepindolol.
Topics: Adult; Chronic Disease; Dose-Response Relationship, Drug; Female; Glomerulonephritis; Humans; Hypert | 1983 |